Apogee Therapeutics Inc. (APGE)
undefined
undefined%
At close: undefined
45.00
1.65%
After-hours Dec 13, 2024, 04:41 PM EST

Income Statement (Annual)

Get detailed income statement breakdowns, uncovering revenue, expenses, and much more.
Year FY23 FY22
Revenue - -
Cost of Revenue - -
Gross Profit - -
Operating Income -93.00M -30.73M
Interest Income 9.02M 92.00K
Pretax Income -83.98M -39.78M
Net Income -83.98M -39.78M
Selling & General & Admin 24.58M 2.94M
Research & Development 68.42M 27.79M
Other Expenses - -
Operating Expenses 93.00M 30.73M
Interest Expense - 9.15M
Selling & Marketing Expenses - -
Cost & Expenses 93.00M 30.73M
Income Tax - -33.52K
Shares Outstanding (Basic) 25.00M 50.67M
Shares Outstanding (Diluted) 25.01M 50.67M
EPS (Basic) -3.36 -0.79
EPS (Diluted) -3.36 -0.79
EBITDA -83.98M -
Depreciation & Amortization 9.02M 33.52M